{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:32:19Z","timestamp":1792017139250,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijpx.2021.100100","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T17:28:33Z","timestamp":1635182913000},"page":"100100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Intravesical drug delivery approaches for improved therapy of urinary bladder diseases"],"prefix":"10.1016","volume":"3","author":[{"given":"Luca","family":"Palugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cerea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Moutaharrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Zema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Melocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Uboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Filippin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Foppoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2021.100100_bb0005","first-page":"9","article-title":"Non-muscle-invasive (TaT1, CIS) Bladder cancer","volume":"1","author":"Babjuk","year":"2019","journal-title":"Eur. Assoc. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jphp.12441","article-title":"The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer","volume":"67","author":"Chatta","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/luts.12262","article-title":"Pathophysiology of refractory overactive bladder","volume":"11","author":"Chen","year":"2019","journal-title":"Low. Urin. Tract Symptoms"},{"key":"10.1016\/j.ijpx.2021.100100_bb0020","article-title":"Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel","volume":"9","author":"Chen","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2021.100100_bb0025","series-title":"Intravesical Drug Delivery Methods and Devices","author":"Cima","year":"2020"},{"key":"10.1016\/j.ijpx.2021.100100_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2014.04.049","article-title":"Single compartment drug delivery","volume":"190","author":"Cima","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100100_bb0035","doi-asserted-by":"crossref","first-page":"e16000","DOI":"10.1200\/JCO.2017.35.15_suppl.e16000","article-title":"Effect of GemRIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC)","volume":"35","author":"Daneshmand","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00345-009-0389-x","article-title":"Updates in intravesical electromotive drug administration\u00ae of mitomycin-C for non-muscle invasive bladder cancer","volume":"27","author":"Di Stasi","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0045","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/nau.24702","article-title":"Safety, tolerability, and efficacy of LiRIS 400mg in women with interstitial cystitis\/bladder pain syndrome with or without Hunner lesions","volume":"40","author":"Evans","year":"2021","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ijpx.2021.100100_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.actbio.2016.01.020","article-title":"Bacteria-responsive multilayer coatings comprising polycationic nanospheres for bacteria biofilm prevention on urinary catheters","volume":"33","author":"Francesko","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2021.100100_bb0055","first-page":"1","article-title":"The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy","volume":"4","author":"Fraser","year":"2002","journal-title":"Rev. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0090-4295(02)02281-1","article-title":"Intravesical liposome administration\u2014a novel treatment for hyperactive bladder in the rat","volume":"61","author":"Fraser","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ijpx.2021.100100_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.10.041","article-title":"Chlorhexidine sustained-release varnishes for catheter coating \u2013 dissolution kinetics and antibiofilm properties","volume":"112","author":"Gefter","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100100_bb0070","series-title":"Drug Delivery Systems and Methods for Treatment of Bladder Cancer with Gemcitabine","author":"Giesing","year":"2015"},{"key":"10.1016\/j.ijpx.2021.100100_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euf.2019.09.006","article-title":"Overview of taris GemRIS, a novel drug delivery system for bladder cancer","volume":"6","author":"Grimberg","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.ijpx.2021.100100_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100100_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.11.031","article-title":"Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery","volume":"245","author":"GuhaSarkar","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100100_bb0090","author":"Hamza"},{"key":"10.1016\/j.ijpx.2021.100100_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/j.1941-9635.2015.tb01419.x","article-title":"Degradation of microcellular PLGA-PEG copolymer for use in a drug delivery system for the urinary bladder","volume":"71","author":"Hopmann","year":"2015","journal-title":"Plast. Eng."},{"key":"10.1016\/j.ijpx.2021.100100_bb0100","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2011.10185.x","article-title":"R11, a novel cell-permeable peptide, as an intravesical delivery vehicle","volume":"108","author":"Hsieh","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.ijpx.2021.100100_bb0105","author":"Innoventions Ltd"},{"key":"10.1016\/j.ijpx.2021.100100_bb0110","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00327.2009","article-title":"Cell biology and physiology of the uroepithelium","volume":"297","author":"Khandelwal","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10218","article-title":"Indwelling urinary catheter assembled with lidocaine-loaded polymeric strand for local sustained alleviation of bladder discomfort","volume":"6","author":"Kim","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ijpx.2021.100100_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2017.08.120","article-title":"Advances in intravesical drug delivery systems to treat bladder cancer","volume":"532","author":"Kolawole","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100100_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0130","series-title":"Intravesical Drug Delivery Devices and Methods Including Elastic Polymer-drug Matrix Systems","author":"Lee","year":"2015"},{"key":"10.1016\/j.ijpx.2021.100100_bb0135","series-title":"Intravesical Drug Delivery Device and Method","author":"Lee","year":"2007"},{"key":"10.1016\/j.ijpx.2021.100100_bb0140","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1066102","article-title":"Biodegradable, elastic shape-memory polymers for potential biomedical applications","volume":"296","author":"Lendlein","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijpx.2021.100100_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11255-016-1251-x","article-title":"Updates of underactive bladder: a review of the recent literature","volume":"48","author":"Li","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0150","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jps.23854","article-title":"In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract","volume":"103","author":"Lin","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100100_bb0155","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s11095-014-1362-y","article-title":"A floating hydrogel system capable of generating Co2 bubbles to diminish urinary obstruction after intravesical instillation","volume":"31","author":"Lin","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2021.100100_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/app.48798","article-title":"Retentive drug delivery systems based on shape memory materials","volume":"137","author":"Maroni","year":"2020","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ijpx.2021.100100_bb0165","series-title":"Intravescical Infuser","author":"Matsuura","year":"2001"},{"key":"10.1016\/j.ijpx.2021.100100_bb0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ogc.2014.05.004","article-title":"Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation","volume":"41","author":"McLennan","year":"2014","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ijpx.2021.100100_bb0175","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1208\/s12249-018-1029-9","article-title":"Industrial development of a 3D-printed nutraceutical delivery platform in the form of a multicompartment HPC capsule","volume":"19","author":"Melocchi","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2021.100100_bb0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2019.01.045","article-title":"Retentive device for intravesical drug delivery based on water-induced shape memory response of poly(vinyl alcohol): design concept and 4D printing feasibility","volume":"559","author":"Melocchi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100100_bb0185","doi-asserted-by":"crossref","first-page":"118700","DOI":"10.1016\/j.ijpharm.2019.118700","article-title":"Expandable drug delivery system for gastric retention based on shape memory polymers: Development via 4D printing and extrusion","volume":"571","author":"Melocchi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100100_bb0190","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.xphs.2020.07.011","article-title":"A graphical review on the escalation of fused deposition modeling (FDM) 3D printing in the pharmaceutical field","volume":"109","author":"Melocchi","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100100_bb0195","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.xphs.2020.02.013","article-title":"Lego-inspired capsular devices for the development of personalized dietary supplements : proof of concept with multimodal release of caffeine","volume":"109","author":"Melocchi","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100100_bb0200","doi-asserted-by":"crossref","first-page":"119901","DOI":"10.1016\/j.ijpharm.2020.119901","article-title":"Quality considerations on the pharmaceutical applications of fused deposition modeling 3D printing","volume":"592","author":"Melocchi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100100_bb0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/pharmaceutics13050759","article-title":"The ChronotopicTM system for pulsatile and colonic delivery of active molecules in the era of precision medicine: feasibility by 3D printing via fused deposition modeling (FDM)","volume":"13","author":"Melocchi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2021.100100_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.addr.2021.03.013","article-title":"Shape memory materials and 4D printing in pharmaceutics","volume":"173","author":"Melocchi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2021.100100_bb0215","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41598-017-02014-6","article-title":"Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery","volume":"7","author":"Nakase","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2021.100100_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003804","article-title":"Continuous intravesical lidocaine treatment for interstitial cystitis\/bladder pain syndrome: safety and efficacy of a new drug delivery device","volume":"4","author":"Nickel","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpx.2021.100100_bb0225","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.actbio.2012.01.032","article-title":"Salicylic acid-releasing polyurethane acrylate polymers as anti-biofilm urological catheter coatings","volume":"8","author":"Nowatzki","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2021.100100_bb0230","series-title":"Drugs R D 3","first-page":"82","author":"Oxybutynin Intravesical \u2014 Situs","year":"2002"},{"key":"10.1016\/j.ijpx.2021.100100_bb0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.tibtech.2019.12.012","article-title":"Intravesical hydrogels as drug reservoirs","volume":"38","author":"Qiu","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0240","series-title":"Recent Research in Pharmaceutical","first-page":"57","article-title":"Nanocarrier mediated urinary bladder targeted drug delivery","author":"Sansare","year":"2021"},{"key":"10.1016\/j.ijpx.2021.100100_bb0245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40684-017-0040-z","article-title":"Review of 4D printing materials and their properties","volume":"4","author":"Shin","year":"2017","journal-title":"Int. J. Precis. Eng. Manuf. Green Technol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0250","author":"Situs Co"},{"key":"10.1016\/j.ijpx.2021.100100_bb0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jddst.2018.11.019","article-title":"Layer-by-layer dip coating of Foley urinary catheters by chlorhexidine-loaded micelles","volume":"49","author":"Srisang","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0260","series-title":"Gray\u2019s Anatomy, The Anatomical Basis of Clinical Practice","author":"Standring","year":"2005"},{"key":"10.1016\/j.ijpx.2021.100100_bb0265","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41585-018-0092-z","article-title":"Intravesical device-assisted therapies for non-muscle-invasive bladder cancer","volume":"15","author":"Tan","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jphotobiol.2015.04.034","article-title":"Inhibitory effect of silver nanoparticle fabricated urinary catheter on colonization efficiency of Coagulase negative Staphylococci","volume":"149","author":"Thomas","year":"2015","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jconrel.2010.05.036","article-title":"Zero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric device","volume":"146","author":"Tobias","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100100_bb0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2016.1100166","article-title":"Advances in intravesical therapy for urinary tract disorders","volume":"13","author":"Tyagi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2021.100100_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12090859","article-title":"Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes","volume":"12","author":"Vigani","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2021.100100_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020166","article-title":"Strategies to get drugs across bladder penetrating barriers for improving bladder cancer therapy","volume":"13","author":"Wang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2021.100100_bb0295","doi-asserted-by":"crossref","first-page":"111773","DOI":"10.1016\/j.msec.2020.111773","article-title":"Stereolithography (SLA) 3D printing of a bladder device for intravesical drug delivery","volume":"120","author":"Xu","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpx.2021.100100_bb0300","series-title":"Intravesicular Baloon","author":"Yachia","year":"2001"},{"key":"10.1016\/j.ijpx.2021.100100_bb0305","series-title":"Intravesicular Device","author":"Yachia","year":"2002"},{"key":"10.1016\/j.ijpx.2021.100100_bb0310","series-title":"Implantable Mecidal Device for Controlled Release of Substance","author":"Yachia","year":"2006"},{"key":"10.1016\/j.ijpx.2021.100100_bb0315","series-title":"Implantable Device Which is Freely Movable in a Body Cavity","author":"Yachia","year":"2006"},{"key":"10.1016\/j.ijpx.2021.100100_bb0320","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/17425247.2020.1810016","article-title":"Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer","volume":"17","author":"Yoon","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2021.100100_bb0325","article-title":"Targeted drug delivery systems for bladder cancer therapy","author":"Yu","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0330","first-page":"169","article-title":"Novel targeted bladder drug-delivery systems: a review","volume":"7","author":"Zacch\u00e8","year":"2015","journal-title":"Res. Rep. Urol."},{"key":"10.1016\/j.ijpx.2021.100100_bb0335","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/19475411.2019.1591541","article-title":"Developments in 4D-printing: a review on current smart materials, technologies, and applications","volume":"10","author":"Zhang","year":"2019","journal-title":"Int. J. Smart Nano Mater."},{"key":"10.1016\/j.ijpx.2021.100100_bb0340","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3109\/10717544.2015.1101791","article-title":"Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release","volume":"23","author":"Zhu","year":"2016","journal-title":"Drug Deliv."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156721000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156721000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:39:12Z","timestamp":1762915152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156721000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":68,"alternative-id":["S2590156721000293"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2021.100100","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical drug delivery approaches for improved therapy of urinary bladder diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2021.100100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100100"}}